Clinical Trial Update: Desidustat in the Treatment of Anemia in CKD on Dialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update for desidustat in treating anemia in chronic kidney disease patients on dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Desidustat (Desidustat)

Snippet

Sponsor: Zydus Lifesciences Limited | Conditions: Chronic Kidney Disease Stage 5 on Dialysis | Phase 3 | Status: COMPLETED